LEHI, UT, UNITED STATES, March 20, 2025 /EINPresswire.com/ — Lumea, a leader in digital pathology solutions. AIRA Matrix Private Limited, an innovative technology company for AI-based diagnostic, prognostic, and predictive…
Lumea’s Digital Diagnostic Suite™ (Viewer+™) Receives FDA 510(k) Clearance* for Clinical Diagnosis LEHI, UTAH, UNITED STATES, March 18, 2025 /EINPresswire.com/ – Lumea, a leader in digital pathology solutions, is proud…
LEHI, UT, UNITED STATES, December 5, 2024 /EINPresswire.com/ — Lumea, a leader in digital pathology solutions, is excited to announce that Cxbladder™, a suite of non-invasive genomic urine tests optimized…
Out of 150 companies recognized, Lumea secured the 33rd spot in the prestigious 2024 Top Workplace Awards LEHI, UT, UNITED STATES, October 16, 2024 – Lumea has been recognized as a Top…
*BxLink has not been approved by the FDA for digital primary diagnosis. Refer to CAP guidelines regarding the use of digital pathology technologies.
